In ovarian cancer, resistant subpopulations exhibiting high ALDH1A1 and S100A4 expression were found to co-localize with lactylation signals, linking metabolic reprogramming directly to spatial stemness niches (131, 132). Here, ALDH1A1 is linked to ovarian cancer.